DocSym
β
Searchsearch
Search
(Z36.1) Antenatal screening for raised alphafetoprotein level
More details coming soon
502 917 in individuals diagnosis antenatal screening for raised alphafetoprotein level confirmed
Diagnosis antenatal screening for raised alphafetoprotein level is diagnosed Women are 99.73% more likely than Men
668
Men receive the diagnosis antenatal screening for raised alphafetoprotein level
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
502 249
Women receive the diagnosis antenatal screening for raised alphafetoprotein level
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease antenatal screening for raised alphafetoprotein level - Men aged 20-24 and Women aged 35-39
In Men diagnosis is most often set at age 20-24
Less common in men the disease occurs at Age 0-19, 25-95+Less common in women the disease occurs at Age 0-9, 50-95+
In Women diagnosis is most often set at age 0-1, 10-49
Disease Features antenatal screening for raised alphafetoprotein level
Absence or low individual and public risk
Antenatal screening for raised alphafetoprotein level - what does this mean
Antenatal screening for raised alphafetoprotein level occurs when a pregnant woman's blood is tested for high levels of the protein, alphafetoprotein. this is usually done between the 15th and 20th week of pregnancy and can indicate a possible birth defect or other abnormality. if the results are positive, further tests may be recommended.
What happens during the disease - antenatal screening for raised alphafetoprotein level
The pathogenesis of antenatal screening for raised alphafetoprotein level is related to a disruption in the normal development of the fetus. this disruption can be caused by genetic or environmental factors, such as exposure to toxins, infections, or drugs. in some cases, the disruption can lead to an increase in the level of alphafetoprotein, which can be detected through antenatal screening. the increased alphafetoprotein level can indicate potential congenital malformations or other medical conditions, and further testing may be needed to confirm the diagnosis.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Perform a physical examination to assess the presence of any abnormalities.
- Order blood tests to measure alphafetoprotein levels.
- Order an ultrasound to assess the fetus for any structural abnormalities.
- Perform a maternal serum screening test.
- Perform a fetal echocardiogram to assess the fetal heart.
- Order an amniocentesis to assess for chromosomal abnormalities.
- Perform a fetal MRI to assess for any neurological abnormalities.
- Perform genetic testing to identify any genetic mutations.
- Order a maternal serum triple screen to assess for any metabolic disorders.
Treatment and Medical Assistance
Main Goal: Treat Raised Alphafetoprotein Level
- Referral to a specialist for further evaluation
- Ultrasound scans to check for any abnormalities in the baby
- Amniocentesis to check for any genetic or chromosomal abnormalities
- Cordocentesis to check for any genetic or chromosomal abnormalities
- Fetal MRI to check for any structural abnormalities
- Follow-up scans to monitor the baby’s development
- Regular blood tests to monitor the mother’s health
- Regular check-ups to monitor the baby’s growth
- Counseling for the mother and family
Less than a Day of Hospitalization Required
58 Hours Required for Outpatient Treatment
Antenatal screening for raised alphafetoprotein level - Prevention
Antenatal screening for raised alphafetoprotein levels is an important preventative measure to identify babies at risk of neural tube defects and other birth defects. during the first trimester of pregnancy, the mother's blood is tested for alphafetoprotein levels, and if the levels are found to be elevated, further testing can be done to diagnose and treat any underlying problems.